FBIO logo

Fortress Biotech (FBIO) Free Cash Flow

Annual FCF

-$136.32 M
+$46.13 M+25.28%

December 31, 2023


Summary


Performance

FBIO Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFBIOcash flowmetrics:

Quarterly FCF

-$20.06 M
+$1.78 M+8.15%

September 30, 2024


Summary


Performance

FBIO Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFBIOcash flowmetrics:

TTM FCF

-$102.28 M
+$2.72 M+2.59%

September 30, 2024


Summary


Performance

FBIO TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFBIOcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

FBIO Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.3%+11.9%+21.1%
3 y3 years-50.1%+52.5%+23.0%
5 y5 years-26.0%+24.7%-3.8%

FBIO Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2.6%+25.3%at high+67.5%at high+47.9%
5 y5-year-50.1%+25.3%-8.6%+67.5%-14.5%+47.9%
alltimeall time-2295.8%+25.3%-669.1%+67.5%-1728.8%+47.9%

Fortress Biotech Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$20.06 M(-8.1%)
-$102.28 M(-2.6%)
Jun 2024
-
-$21.84 M(-14.0%)
-$105.00 M(-11.4%)
Mar 2024
-
-$25.39 M(-27.5%)
-$118.49 M(-13.1%)
Dec 2023
-$136.32 M(-25.3%)
-$35.00 M(+53.6%)
-$136.32 M(+5.2%)
Sep 2023
-
-$22.78 M(-35.5%)
-$129.56 M(-14.2%)
Jun 2023
-
-$35.33 M(-18.3%)
-$151.07 M(-14.9%)
Mar 2023
-
-$43.22 M(+53.1%)
-$177.48 M(-2.7%)
Dec 2022
-$182.46 M(+37.3%)
-$28.23 M(-36.3%)
-$182.46 M(-7.1%)
Sep 2022
-
-$44.29 M(-28.2%)
-$196.42 M(+8.3%)
Jun 2022
-
-$61.73 M(+28.1%)
-$181.37 M(+14.1%)
Mar 2022
-
-$48.20 M(+14.2%)
-$158.94 M(+19.6%)
Dec 2021
-$132.89 M(+46.3%)
-$42.20 M(+44.3%)
-$132.89 M(+17.9%)
Sep 2021
-
-$29.24 M(-25.6%)
-$112.74 M(+2.3%)
Jun 2021
-
-$39.30 M(+77.5%)
-$110.15 M(+23.3%)
Mar 2021
-
-$22.15 M(+0.4%)
-$89.32 M(-1.7%)
Dec 2020
-$90.85 M(-12.9%)
-$22.05 M(-17.2%)
-$90.85 M(-7.8%)
Sep 2020
-
-$26.65 M(+44.2%)
-$98.53 M(+7.2%)
Jun 2020
-
-$18.48 M(-21.9%)
-$91.90 M(-10.3%)
Mar 2020
-
-$23.67 M(-20.4%)
-$102.40 M(-1.9%)
Dec 2019
-$104.36 M(-3.6%)
-$29.74 M(+48.6%)
-$104.36 M(+6.1%)
Sep 2019
-
-$20.01 M(-30.9%)
-$98.31 M(-7.4%)
Jun 2019
-
-$28.98 M(+13.1%)
-$106.19 M(+1.0%)
Mar 2019
-
-$25.63 M(+8.1%)
-$105.14 M(-2.8%)
Dec 2018
-$108.20 M(+26.8%)
-$23.70 M(-15.0%)
-$108.20 M(+0.7%)
Sep 2018
-
-$27.89 M(-0.1%)
-$107.42 M(+1.9%)
Jun 2018
-
-$27.93 M(-2.6%)
-$105.45 M(+3.8%)
Mar 2018
-
-$28.68 M(+25.2%)
-$101.60 M(+19.1%)
Dec 2017
-$85.32 M
-$22.91 M(-11.6%)
-$85.32 M(+4.5%)
DateAnnualQuarterlyTTM
Sep 2017
-
-$25.93 M(+7.7%)
-$81.68 M(+21.9%)
Jun 2017
-
-$24.08 M(+94.2%)
-$67.03 M(+22.9%)
Mar 2017
-
-$12.40 M(-35.7%)
-$54.55 M(-3.1%)
Dec 2016
-$56.32 M(+74.0%)
-$19.27 M(+70.9%)
-$56.32 M(+25.7%)
Sep 2016
-
-$11.28 M(-2.8%)
-$44.82 M(+11.7%)
Jun 2016
-
-$11.60 M(-18.1%)
-$40.12 M(+10.1%)
Mar 2016
-
-$14.16 M(+82.2%)
-$36.44 M(+12.6%)
Dec 2015
-$32.36 M(+98.1%)
-$7.78 M(+18.1%)
-$32.36 M(+15.1%)
Sep 2015
-
-$6.58 M(-16.9%)
-$28.11 M(+15.9%)
Jun 2015
-
-$7.92 M(-21.5%)
-$24.25 M(+19.2%)
Mar 2015
-
-$10.08 M(+185.9%)
-$20.34 M(+24.6%)
Dec 2014
-$16.33 M(-45.3%)
-$3.53 M(+29.7%)
-$16.33 M(-18.1%)
Sep 2014
-
-$2.72 M(-32.3%)
-$19.94 M(-18.2%)
Jun 2014
-
-$4.01 M(-33.9%)
-$24.36 M(-14.3%)
Mar 2014
-
-$6.07 M(-14.8%)
-$28.41 M(-4.8%)
Dec 2013
-$29.83 M(+27.1%)
-$7.13 M(-0.1%)
-$29.83 M(+0.1%)
Sep 2013
-
-$7.14 M(-11.5%)
-$29.81 M(+9.1%)
Jun 2013
-
-$8.07 M(+7.6%)
-$27.32 M(+8.2%)
Mar 2013
-
-$7.49 M(+5.5%)
-$25.26 M(+8.9%)
Dec 2012
-$23.47 M(+58.7%)
-$7.11 M(+52.5%)
-$23.19 M(+17.4%)
Sep 2012
-
-$4.66 M(-22.4%)
-$19.75 M(+9.6%)
Jun 2012
-
-$6.01 M(+10.7%)
-$18.02 M(+23.2%)
Mar 2012
-
-$5.42 M(+48.2%)
-$14.63 M(-1.1%)
Dec 2011
-$14.79 M(+160.0%)
-$3.66 M(+24.8%)
-$14.79 M(+32.9%)
Sep 2011
-
-$2.93 M(+12.5%)
-$11.13 M(+35.8%)
Jun 2011
-
-$2.61 M(-53.4%)
-$8.20 M(+46.6%)
Mar 2011
-
-$5.59 M
-$5.59 M
Dec 2010
-$5.69 M
-
-

FAQ

  • What is Fortress Biotech annual free cash flow?
  • What is the all time high annual FCF for Fortress Biotech?
  • What is Fortress Biotech annual FCF year-on-year change?
  • What is Fortress Biotech quarterly free cash flow?
  • What is the all time high quarterly FCF for Fortress Biotech?
  • What is Fortress Biotech quarterly FCF year-on-year change?
  • What is Fortress Biotech TTM free cash flow?
  • What is the all time high TTM FCF for Fortress Biotech?
  • What is Fortress Biotech TTM FCF year-on-year change?

What is Fortress Biotech annual free cash flow?

The current annual FCF of FBIO is -$136.32 M

What is the all time high annual FCF for Fortress Biotech?

Fortress Biotech all-time high annual free cash flow is -$5.69 M

What is Fortress Biotech annual FCF year-on-year change?

Over the past year, FBIO annual free cash flow has changed by +$46.13 M (+25.28%)

What is Fortress Biotech quarterly free cash flow?

The current quarterly FCF of FBIO is -$20.06 M

What is the all time high quarterly FCF for Fortress Biotech?

Fortress Biotech all-time high quarterly free cash flow is -$2.61 M

What is Fortress Biotech quarterly FCF year-on-year change?

Over the past year, FBIO quarterly free cash flow has changed by +$2.72 M (+11.94%)

What is Fortress Biotech TTM free cash flow?

The current TTM FCF of FBIO is -$102.28 M

What is the all time high TTM FCF for Fortress Biotech?

Fortress Biotech all-time high TTM free cash flow is -$5.59 M

What is Fortress Biotech TTM FCF year-on-year change?

Over the past year, FBIO TTM free cash flow has changed by +$27.28 M (+21.05%)